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Abstract
We describe, for the first time, the use of a mobile device platform for remote direct observa-
tion of inhaler use and technique. The research programme commenced with a rapid sys-
tematic review of mobile device (or videophone) use for direct observation of therapy
(MDOT). Ten studies (mainly pilots) were identified involving patients with tuberculosis,
sickle cell disease and Alzheimer’s disease. New studies are ongoing (ClinicalTrials.gov
website) in TB, stroke, sickle cell disease, HIV and opioid dependence. Having identified no
prior use of MDOT in inhaler monitoring, we implemented a feasibility study in 12 healthy
volunteer children (2–12 years; 8 females and 4 males) over a period of 14 days, with twice
daily video upload of their ’dummy’ inhaler use. Two children uploaded 100% of the
requested videos, with only one child having an inhaler upload rate of <75%. The quality of
uploaded videos was generally good (only 1.7% of unacceptable quality for evaluation). The
final aspect of the research was a pilot study using MDOT (6 weeks) in 22 children with diffi-
cult to treat asthma. Healthcare professionals evaluated inhaler technique using uploaded
videos and provided telephone instruction on improving inhaler use. The main outcomes
were assessed at week 12 post initiation of MDOT. By week 5, all children still engaging in
MDOT (n = 18) were judged to have effective inhaler technique. Spirometry values did not
vary to a significantly significant degree between baseline and 12 weeks (P>0.05), however,
mean fraction of exhaled nitric oxide (FeNO) values normalised (mean 38.7 to 19.3ppm)
and mean Asthma Control Test values improved (13.1 to mean 17.8). Feedback from partic-
ipants was positive. Overall the findings open up a new paradigm in device independent
(can be used for any type of inhaler device) monitoring, providing a platform for evaluating /
improving inhaler use at home.
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Introduction
Asthma is a health problem affecting approximately 253 million people worldwide and it is the
most common non-communicable illness in children [1]. Many studies have reported that the
majority of patients (50%-80%) fail to use effective inhaler technique and this inadequate
inhaler use is one of the reasons for the high prevalence of uncontrolled asthma [2–4]. More-
over, it has been noted that most patients overestimate their inhaler use capability and are not
aware of making mistakes during inhaler use [5,6]. Although inhaled corticosteroid therapy
(ICS) is central to asthma management, some patients do not use their treatment as prescribed
and indeed the average medication adherence to inhaled corticosteroid (ICS) in children is
documented to be around 50% [7,8]. To achieve optimal outcomes, it is not only imperative
that children adhere to the regular use of their ICS (normally twice per day) but that they
adhere to correct inhaler technique, allowing the medicine to penetrate into, and be deposited
deep within, the lungs [5].
Non-adherence to medication in children with asthma can have various negative conse-
quences such as frequent clinic visits, disease exacerbation and hospital admission, all of which
lead to an increased cost of care [4,9]. Indeed, a review of childhood asthma deaths in SE
England showed that medication non-adherence was a contributing factor in more than 50%
of cases, including patients with milder disease [9]. A multicentre clinical trial in the USA was
designed to determine what medication was best to add in children with severe asthma already
receiving ICS and long acting beta agonist (LABA) treatment. In this latter study the run-in
period was not fixed and children were only randomised to therapy after they had demon-
strated good adherence, including good inhaler technique. Interestingly, the trial was cut short
due to an inability to recruit an adequate number of children. Patient improvement while
under close supervision during the run in period was the main reason for the lack of patient
recruitment [10] showing that intense monitoring and improved adherence led to the asthma
becoming better controlled.
New therapies for children with uncontrolled asthma such as anti-IgE therapy (omalizu-
mab) are very expensive and thus in the UK most large paediatric respiratory centres have set
up specific ‘problem, severe asthma’ clinics. These regional centres should have the ability to
confirm the asthma diagnosis, ensure that concomitant conditions are treated and, most
importantly, confirm that the children still have symptoms after a period of optimised therapy
(including good adherence to ICS and good inhaler technique). With the exception of directly
observing therapy, there is currently no adequate generalizable method or tool to determine
whether the therapy has been optimised i.e. that enables the doctor to know that the child has
used his/her inhaler regularly and correctly. This involves a healthcare professional regularly
visiting the patient at home or school for a period of 6 to 12 weeks which is very costly and
labour intensive. There is a pressing need for a convenient, simple tool that could mimic this
direct observation of therapy (DOT) without the staff and travel costs.
DOT has been promoted by the WHO to enhance the adherence of patients with tuberculo-
sis (TB) [11,12]. A new development within the DOT arena, linked to the trend of the
increased use of mobile IT devices within the healthcare field, has been the introduction of
mobile DOT (MDOT). This emerging approach to assessing treatment adherence, involves a
patient recording a video of their treatment administration at home on a mobile device (e.g.
on their mobile phone, tablet or videophone) and then sending it electronically for observation
by a healthcare provider [13,14]. MDOT has the potential to significantly reduce the cost asso-
ciated with traditional DOT and has been shown to be effective in TB patients [14] and in
patients with sickle cell disease [13] in whom good medication adherence is imperative. For
example, a smartphone application was developed specifically for applying a MDOT approach
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to enhance paediatric hydroxyurea medication adherence in children with sickle cell disease
[13]. This latter approach resulted in a median adherence of 93.3% over a six month period.
The aim of the present study was threefold: (a) to carry out a rapid systematic review of the
use of MDOT within healthcare, and in particular its prior use in asthma management, (b) to
carry out a healthy volunteer study to assess the feasibility of using MDOT to monitor / evalu-
ate inhaler use in children and (c) perform a pilot study of the use of MDOT in children with
difficult to control asthma.
Methods
Rapid systematic review
The methodological protocol for this rapid review followed the guidance outlined by Khan-
gura et al. [15]. The literature search was carried out in April / June 2015.
All the published studies (English language) which utilised a MDOT technique were
included regardless of the age or disease condition of the participants. For the purposes of this
review, any study which used a video phone, smartphone or other mobile device to record a
video of treatment administration at home, in which the video could be remotely observed by
a healthcare provider, was included.
Six different databases i.e. MEDLINE; Scopus; Web of Science; International Pharmaceuti-
cal Abstracts (IPA); PubMed and EMBASE were rigorously searched using the following sub-
ject headings (MeSH terms) and keywords:
("video recording" OR smartphone /or handheld device OR Telemedicine / or mobile video
OR Social media /or mobile applications) AND (directly observed therapy / or "direct
observed" OR "directly observed" OR "direct observation"). The reference lists in each study
identified were also searched for relevant studies.
In addition, an electronic online search was carried out via Google1 in order to search
more widely for undiscovered studies, grey literature and conference abstracts. The Clinical-
Trail.gov website was also searched for new / ongoing clinical trials that were relevant to the
review.
Having removed duplicates, full-text versions of the research articles were obtained. Studies
that were not available in full-text version format were excluded (n = 2). The quality of the arti-
cles were assessed by three of the authors (FA, JM and MR) using the Downs and Black [16]
instrument (as modified by Eng et al.) [17]. This tool has been shown to be valid and reliable
in assessing randomised and non-randomised studies and contains 27 items arranged in four
sub-scales, i.e. reporting, external validity, internal validity and power (score range 0–28; excel-
lent 26–28; good 20–25; fair 15–19; poor<14). The outcome of the review is presented in the
results section of this paper. No prior use of MDOT approach in asthma management was
identified.
Feasibility study–healthy volunteer children
The aim of this aspect of the research programme was to evaluate the feasibility of using the
MDOT approach to capture the use of ‘dummy’ inhalers in a small cohort of healthy volunteer
children (n = 12) ahead of carrying out a pilot clinical study in paediatric patients with difficult
to control asthma. A simple MDOT platform was developed which was compatible with all
brands of smartphone, tablets or other devices that could be connected to the internet, and
allowed video recording and encrypted transmission to a secure, password protected Univer-
sity server.
The study protocol was approved by the School of Pharmacy Ethics Committee (School
Ref: 014PMY2014). A convenience sample involving children of staff working in health and
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social science departments in Queen’s University was recruited, i.e. via an email invitation,
staff members were invited to take part in the study if they had children between the ages of 2
and 12 years old who did not suffer from asthma and who did not use an inhaler for any other
condition. In addition, to be enrolled on to the study, parents (i) had to have a smartphone,
tablet or other mobile device that could capture video clips and connect to the internet, (ii)
had to have internet access at home and (iii) were required to provide written informed con-
sent to their child’s participation. Children over 6 years old were required to provide their
assent to join the study. Once enrolled in the study, the MDOT platform was set up on each
parent’s /guardian’s smartphone, tablet (or other mobile device) to allow video capture and
encrypted transmission. Parents/ guardians (and their children) were instructed in correct
inhaler use and were asked to facilitate the capture and upload of two video recordings daily
(morning and evening) of the use of the dummy inhaler by their child over a period of two
weeks. For children up to the age 6 years old, a mask and holding chamber was used with the
dummy inhaler. In general the parents/guardians ‘administered’ the inhaler for children up to
6 years old while children 6 years old and above were asked to use the dummy inhaler by them-
selves. A member of the research team (FA) reviewed video uploads on a daily basis, through
password protected access to the repository and followed up with the parent/guardian by tele-
phone if two consecutive days of video uploads were missed.
When the two week period of video collection was completed, parents/guardians and chil-
dren over 6 years old were invited to take part in a joint interview to provide their views and
experience regarding the use of the technology. A topic guide was developed to guide the inter-
views. During interviews with children, simplified language appropriate to their ages was used.
All interviews were audio recorded and transcribed in full. The software package NVivo (IQSR
international, version 10) was used to store and manage / analyse interview transcripts.
Having completed all video collections, an assessment of video quality was undertaken to
determine whether the videos were of good enough quality to assess inhaler use. Five videos
were randomly selected (random number generation; www.random.org) for each child i.e. 60
videos in total for the 12 participating children. The video quality was categorised as: (i)
acceptable video quality, when the video had good clarity, framing, image stability and would
be suitable for assessing the various steps required for scoring inhaler technique, (ii) margin-
ally acceptable video quality was recorded when there was some aspect that affected video clar-
ity or resolution but a general assessment of inhaler technique would still be possible and (iii)
Unacceptable video quality was recorded when the video image was not clear and it would not
be possible to score the inhaler steps (e.g. poor lighting) or when two or more steps in inhaler
use were not clearly visible in the video recording. This evaluation was performed indepen-
dently by each member of the research team (n = 4)
The primary outcome measures for this feasibility study related to the connectivity and
usability of the MDOT system and therefore primarily related to (a) the number of days in
which videos were loaded and (b) the quality of uploaded videos. Barriers to using the MDOT
platform and to loading the videos on to the repository developed specifically for the study
were determined via the interviews.
All numerical and categorical data collected during the study were analysed using descrip-
tive approaches while the interview transcripts were analysed qualitatively (thematic analysis)
[18,19].
Pilot study in children with asthma
Having achieved encouraging results in the feasibility study, attention turned to a pilot study
in children with difficult to manage asthma. The study protocol was granted a favourable
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ethical opinion (reference number: 14/NI/1099) from the Research Ethics Committees North-
ern Ireland (ORECNI) and is registered with ClinicalTrials.gov PRS (reference number:
NCT03248895). Parents / guardians and their children were recruited at outpatient appoint-
ments at two sites in the Belfast Health & Social Care Trust i.e. Royal Belfast Hospital for Sick
Children (RBHSC) and the Trust’s Community Asthma Clinic.
Study design. A randomised intervention trial design was used in which participants
were randomised to receive either an immediate (IM) or a delayed (DE) MDOT intervention.
Randomisation was restricted [20] based on two factors i.e. age (categorised as ‘young chil-
dren’ aged 2 to 5 years; ‘children’ aged 5 to 12 years; ‘young people’ aged 12 to 16 years) and
patient gender.
Participants allocated to the IM group participated in the MDOT intervention for the first 6
weeks of the study. Those participants allocated to the DE group commenced the MDOT
intervention after a 6 week “intervention-free” period, with usual Asthma Clinic care up to
that point. The original plan was to recruit 72 children (36 per group). Although the MDOT
approach was well accepted by clinicians (including asthma nurses), parents and patients, due
to research staffing pressures a lower sample size was achieved (n = 24). The main focus was
therefore on combined data at study baseline and endpoint, i.e. baseline and 12 weeks post ini-
tiation of the MDOT intervention.
Recruitment of participants. The parents/guardians of children and young people with
asthma (aged from 2 to16 years) who had continuing symptoms of partially controlled or
uncontrolled asthma, despite receiving specialist asthma clinic care, were invited to participate
in the research i.e. children who had asthma symptoms despite being prescribed ICS (> 400
mcg/day budesonide equivalent for children < 5 years, or 800 mcg/day budesonide equivalent
for children > 5 years) and a second line therapy such as a long acting beta agonist (LABA),
leukotriene receptor antagonist (LTRA) or theophylline [21]. Access to a suitable mobile
device and internet connection at home, as for the feasibility study, was also required. Subjects
were only included in the study after obtaining written informed consent from their parents/
guardians and assent from children older than 6 years. Recruitment of participants began in
August 2015 and follow-up completed by the end of September 2016.
All subjects (parents and children as appropriate) were trained, on proper inhaler technique
(by a respiratory nurse) using the Teach-to-Goal (TTG) approach [22] and received standard-
of-practice asthma education and management in the Asthma Clinic prior to study enrolment
i.e. educated about the role of medications in asthma management, the importance of regular
preventer therapy and were able to demonstrate good inhaler technique.
Intervention and data collection. Before the study intervention period was initiated in a
given subject, the participant and/or parents/guardians were trained in use of the MDOT plat-
form. Children aged 8 years were asked to use the MDOT approach independently while
parent/guardian assistance was recommended for younger children. Usual asthma treatment
for each participant was used throughout the study. Regarding inhaler use, in general children
aged 5 years or older administered the medication themselves while a parent/guardian was
responsible for inhaler administration in patients 2 to 5 years of age, however, parent/guardian
administration was acceptable if that was usual asthma care in any age of child.
Participants (or parents/guardians of participants) were asked to capture a MDOT video
twice daily as in the feasibility study. A member of the research team evaluated the MDOT
uploads daily through password protected access to the University based digital repository and
followed up with parents/guardians and/or participants by telephone if two consecutive days
of video uploads were missed. The asthma clinical team (consultant/nurse) was notified about
children identified with poor inhaler technique; they viewed the videos and contacted the par-
ticipants by telephone to provide advice on improving inhaler technique.
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Outcome measurements. The range of measures at baseline were as follows:
1. Participant demographics and relevant clinical data including laboratory data and comor-
bid conditions.
2. Clinician assessment of asthma severity and degree of disease control i.e. controlled, par-
tially controlled, or uncontrolled [23].
3. Asthma medication profile and any changes made at the clinic visit.
4. Number of asthma attacks, oral corticosteroids courses, and emergency attendances over
the previous year.
5. Spirometry measurements (FEV1, FVC, FEV1/ FVC)
6. Fraction of exhaled nitric oxide (FeNO)
7. Self-reported Medication Adherence Report Scale (MARS)–appropriate scales for parent/
guardian and child if 9 years of age or greater [24–26].
8. Interview-administered Pediatric Asthma Quality of Life Questionnaire (PAQLQ) if child
>9 years of age, and the Pediatric Asthma Caregiver Quality of Life Questionnaire
(PACQLQ) [27].
9. Interview-administered Asthma Control Test (ACT) or Childhood Asthma Control Test
(C-ACT) [28, 29] for children aged to 12 to 16 and 4 to 11 years respectively.
At six weeks and 12 weeks post commencement of the MDOT intervention, outcome mea-
sures ii to ix were repeated during return visits to the clinic.
Assessment of adherence. In addition to the MARS questionnaire approach to assess
adherence to ICS (see above), GP prescribing records for the 12 months prior to study com-
mencement were collected and analysed using the medication refill adherence (MRA)
approach described by Hess et al. [30] to ascertain baseline adherence. Adherence to MDOT
video uploads was also assessed during the 6 week MDOT intervention in all participants. A
patient was classified as adherent if the MRA value was80% to<120% and non-adherent if
MRA< 80%. If the MRA was found to be>120% this was considered as oversupply. This clas-
sification method was utilised by previous researchers [31–34]. Patients were classified as
adherent if the MARS (parent; child) score was 80% of the maximum score achievable in the
respective versions (parent and child) of the MARS questionnaire.
Assessment of asthma severity and inhaler technique. Clinician assessment of par-
ticipant asthma severity was defined according to accepted guidelines and asthma control
was categorised as uncontrolled, partially controlled, or controlled [23]. Patient inhaler tech-
nique was evaluated by reviewing each video uploaded in the first 2 days of the intervention
period and then via a weekly review of videos uploaded to the repository. Inhaler technique
was categorised on a three-point scale as effective, partially effective or poor [35]. Inhaler tech-
nique evaluation was based on the individual steps relevant to the type of inhaler being used
by individual children (manufacturer administration directions). Effective technique was
recorded when the participant met all relevant criteria for their inhaler type. Partially effective
technique was recorded when errors in technique were observed but it was thought that the
participant would receive some medication. Poor inhaler technique was recorded when critical
errors in technique occurred and it was considered unlikely that any medication would be
inhaled [35,36]. Sample videos was reviewed and scored by two members of the research team
(FA; JM).
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Feedback questionnaire. Parents/guardians were asked to complete an ‘open question’
feedback questionnaire to provide their views and experience with the use of the technology at
the end of intervention period. Feedback questionnaires were sent to each participant by post
and each participant was contacted by telephone as a reminder if the questionnaire was not
returned within a two week period. Two feedback questionnaires were used: one for partici-
pants who completed the 6 week period of using MDOT and the second for participants who
consented to take part but did not upload videos or who uploaded videos for a shorter period
that the 6 weeks requested.
Data management and analysis. All data were coded as appropriate and entered into a
study database (SPSS1 version, 21, USA). All categorical data collected during the pilot study
were analysed using percentages and proportions. Continuous variables were described using
mean and standard deviation (SD) or if skewed median and interquartile range (IQR). Stan-
dard statistical methodology (t-test and Mann-Whitney U test) were used to compare outcome
data.
Results and discussion
Rapid systematic review (RSR)
The methodological approach used in this review mirrored the approach used by Khangura
et al. [15]. Several published RSRs have used this latter methodology [37–39]. This review tech-
nique provides a quick approach to evaluate current evidence on a selected topic [40].
Fig 1 presents the number of studies at each stage of the selection process, including reasons
for study exclusion. A total of only10 studies remained for inclusion in the main aspect of the
review. Only non-randomised studies on the subject had been published. The highest score
achieved for any of the studies, using the modified Downs and Black instrument [16,17], was
20 (out of a maximum possible score of 28), and the lowest score was 5. The median score for
all the articles was 11.3 which equates to poor quality. It can be concluded that MDOT studies
performed to date have suboptimal design / reporting and therefore results need to be consid-
ered with caution.
All the published studies were conducted to assess treatment adherence in tuberculosis,
with the exception of two studies: one involving in the treatment of children with sickle cell
disease and the second involving dementia. The majority of the research was carried out in the
USA (six studies), while two studies were performed in Australia. Single studies were per-
formed in several other countries: Kenya, Mexico and Canada. Relevant information from the
studies were systematically extracted and are summarised Table 1. Six of the studies were
described by their authors as pilot studies. All these pilot studies demonstrated that utilising
technology for monitoring adherence via a MDOT approach was feasible, economical and
practical, including in one study when used by patients with mild dementia [13,41,45,47,49].
The majority of the studies reported that the IT supported approach has the potential to
improve treatment adherence, with rates of adherence of over 80% reached. Two of the pilot
studies involved paediatric patients (hydroxyurea treatment and tuberculosis treatment).
Four retrospective studies reported on the cost effectiveness of MDOT use compared with
regular direct observation of patients at the clinic (DOT) [42,44,46,49].
Numerous advantages and several barriers were identified in published studies from a
patient perspective and from a healthcare system perspective (Table 2). The majority of the
studies revealed that video recording via mobile phone / videophone was straightforward and
patients were highly satisfied with using such an approach.
Furthermore, most patients believed that the MDOT approach provided a flexible and con-
venient method of ensuring medication adherence, compared with the inconvenience of
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attending a clinic [44]. In general, the time taken to record each video was less than five min-
utes and this did not affect the daily routine of the patients [13,49]. Moreover, healthcare pro-
viders were generally satisfied with the MDOT approach [44,45].
Despite the benefits of using the MDOT approach in monitoring medicine adherence at
home, some barriers were reported (Table 2). The main impediment to using the MDOT
approach at home was poor mobile network or internet coverage. However, ongoing mobile
network upgrades and the burgeoning number of patients who have access to broad band
internet within their home will help overcome these obstacles. A further barrier was a degree
of patient concern regarding confidentiality (specifically mentioned in 4 of the 10 studies). A
Fig 1. Study extraction and selection process in rapid systematic review (RSR).
https://doi.org/10.1371/journal.pone.0190031.g001
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Table 1. Summary of the characteristics of the study included in the rapid systematic review (RSR).
Author,
Year,
Country
Title and Journal Device used for
recording video of
treatment and study
duration
Method:
intervention/ sample
size /age group of
participants
Aim of study Findings Conclusions
Garfein
et al.,
2015. [41]
USA and
Mexico
Feasibility of
tuberculosis
treatment monitoring
by video directly
observed therapy: a
Binational pilot study
International
Journal of
Tuberculosis and
Lung Disease
Smartphone.
The recording lasted
for approximately 5
months.
Pilot study recruited 52
patients (18–86 years)
from San Deigo (US)
and Tijuana (Mexico).
Recorded video of
treatment administration
and submitted to be seen
by health worker.
To investigate, using
videophone recording,
adherence to TB
treatment in two
countries, US and
Mexico. Also, examined
the extent of patient
satisfaction.
The adherence rate
was comparable in the
two nations; 90% (San
Deigo) and 96%
(Tijuana). Mobile use
in this study was
highly acceptable.
Video directly observed
therapy is a satisfactory
approach and can be
used to assess adherence
in rich or poor resource
countries.
Mirsaeidi
et al.,
2015. [42]
USA
Video directly
observed therapy for
treatment of
tuberculosis is
patient-oriented and
cost-effective.
European
Respiratory Society.
Mobile phone or
laptop. The majority
of participants used
this approach up to 4
months (64%) while
24% used it up to 8
months.
Retrospective study; 20
patients used DOT
method and were
compared with 11
patients who used
videophone assessed
DOT (19–64 years old).
Assessment of the cost
effectiveness of
observation and the level
of satisfaction with the
videophone DOT
approach.
All videophone
patients (n = 11)
completed the study. 9
patients used a mobile
phone or a laptop for
observation.
Recorded rate of
adherence was 97%.
Observation via mobile
phone was feasible and
had a high tendency to
improve adherence and
save costs.
Creary
et al.,
2014. [13]
USA
A pilot study of
electronic directly
observed therapy to
improve hydroxyurea
adherence in
paediatric patients
with sickle-cell
disease.
Pediatric Blood and
Cancer
Smartphone or
computer.
The study duration
was 6 months.
Electronic observed
therapy method was
used to measure
adherence of
hydroxyurea in 15
patients (1–22 years)
with sickle cell disorder.
To study the feasibility
of electronic adherence
monitoring of
hydroxylurea in children
via recording treatment
using mobile phone
application or computer.
Fourteen children
completed the pilot
study. The median of
treatment adherence
was 93.3%. The
approach had a high
rate of acceptance.
Recording medicine
taking via electronic
device was feasible,
highly acceptable and
could be utilised to
promote adherence.
Gassanov
et al.,
2013. [43]
Canada
The use of
videophone for
directly observed
therapy for the
treatment of
tuberculosis
Canadian Journal of
Public Health
Video phone. The
trial duration was five
weeks.
Pilot study involved 13
patients who successfully
adhered to DOT at
clinic. Patients supplied
with a video enabled
telephone to use at
home, with network
connection to clinic for
observation remotely.
To evaluate video DOT
flexibility in the delivery
of video enabled DOT
method at home.
Videophone was
convenient and had
flexibility for
observation. The rate
of adherence for
patients attending
clinic (DOT) method
(98%) was comparable
to patients using
videophone method at
home (98%).
Recording by videophone
at home had comparable
outcomes to DOT at
clinic.
Wade
et al.,
2012. [44]
Australia
Home videophones
improve direct
observation in
tuberculosis: A mixed
methods evaluation.
Public Library Of
Science (PLOS ONE)
Video phone. The
video recording was
for a 4 month period.
Retrospective study
using qualitative and
quantitative approaches.
58 patients used
videophone service while
70 patients were
observed personally at
home. The study
recruited children and
adults. Participant’s age
ranged between 19 and
60 years.
To evaluate the
feasibility and economic
benefit of using video
phone observation at
home compared with
direct clinic observation
of administration of
tuberculosis therapy.
Lower percentage of
missed observations by
the video phone group
(12%) compared with
31.1% in the direct
clinic observation
group. Fewer staff and
less time required for
video phone group.
Directly observing TB
patients via video phone
was more effective than
directly observing them
in the clinic, and led to
cost savings. The video
phone service was
associated with more
flexibility, patient
acceptability and
efficiency in relation to
healthcare professional
time.
(Continued)
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number of studies highlighted the fact that that they used a protocol to encrypt videos as part
of collection and transmission process to reduce the possibility of unauthorised access. A fur-
ther issue highlighted by Garfein et al. [41] was that the MDOT approach may not be suitable
Table 1. (Continued)
Author,
Year,
Country
Title and Journal Device used for
recording video of
treatment and study
duration
Method:
intervention/ sample
size /age group of
participants
Aim of study Findings Conclusions
Hoffman
et al.,
2010. [45]
Kenya
Mobile direct
observation treatment
for tuberculosis
patients: A technical
feasibility pilot using
mobile phones in
Nairobi, Kenya.
American Journal of
Preventive Medicine
Mobile phone.
study carried out for
4 week period (five
days/ week)
Pilot study involved
3 health care providers
and 11 patients (all
patients <29 years
except for one patient
over 40 years old).
Recorded video of TB
medicine
administration and
submitted via mobile
phone.
To study the feasibility
of observing TB patient
administering
medication remotely via
the mobile DOT
approach.
All participants
completed the study. 8
patients preferred to
use mobile phone
rather than coming to
hospital for
observation.
MDOT observation was
feasible and the approach
was satisfactory for the
majority of participants.
Krueger
et al.,
2010. [46]
USA
Videophone
utilization as an
alternative to direct
observation therapy.
International
Journal of
Tuberculosis and
Lung Diseases
Videophone.
Recording was for an
average of 20 weeks.
Retrospective study
covering period between
2002–2006.
57 patients used
videophone technology.
To assess cost
effectiveness of the
videophone as an option
for performing DOT
approach in TB patients.
The rate of adherence
with TB recorded
treatment via
videophone was high.
A total of US $ 139,
546 was saved on the
cost of transport and
healthcare provider
observation time.
Videophone observation
for treatment was a valid
method and can be used
to improve adherence.
Wade
et al.,
2009. [47]
Australia
Videophone delivery
of Medication
Management in
Community Nursing
Electronic Journal of
Health Informatics
Video phone. Study
was carried out for 6
months.
Pilot study recruited 9
TB patients with mild
cognitive/ impairment.
Participants aged
between 61and 85 years.
To evaluate the usability
and potential use of
videophone to remotely
observe TB therapy
administration at the
patients’ homes.
Positive attitude
recorded toward use of
this technology from
patients and staff. It is
useful for saving time
and costs related to
home visiting.
Videophone provides an
efficient alternative
approach to assess
therapy at the patient’s
home instead of visiting
the patient’s home. 6
(67%) patients would like
to continue use of the
mobile technology.
Smith
et al.,
2007. [48]
USA
Tele-health home
monitoring of solitary
persons with mild
dementia
American Journal of
Alzheimer’s Disease
and other Dementias
Videophone. This
study was carried out
with patients for an
average of 6 months.
Compared video phone
monitoring group (8
patients) with a control
group (6 patients). Age
of participants range
(79–85 years).
To assess technical
feasibility of the
approach, medication
administration and
mood in patients with
dementia.
The technical success
of using the
videophone was 82%.
Video phone
adherence was 81%,
while adherence was
only 66% in control
patients.
Telemonitoring of
patient treatment via
videophone led to
maintaining dementia
patients’ adherence, but
there was no clear
influence on patient
mood.
Demaio
et al.,
2001. [49].
USA
The application of
telemedicine
technology to
observed therapy
programme for
tuberculosis: A pilot
project
Clinical Infectious
Disease
Videophone system
was connected with
touch phone or
television. Study
duration was not
mentioned.
Pilot study using
videophone to connect
between patients’ homes
and healthcare centre for
treatment observation.
Six patients used DOT
method then switched to
using the videophone
method.
To assess the use of
video phone for direct
observation of TB
patient medicine
administration and
compare this with DOT
method.
The recorded rate of
videophone adherence
was 95% while it was
97% for direct
observation at the
clinic. The average
time for video phone
observation was 3
minutes, while direct
observation at the
clinic needed one
hour.
Videophone can lead to
sustainable adherence
and can be a cost
effective approach.
DOT = Direct Observation of Therapy
https://doi.org/10.1371/journal.pone.0190031.t001
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for some types of patients, e.g. individuals with severe arthritis or poor vision may be unable to
join a MDOT programme unless they have a partner or helper who can assist with the process.
As a supplementary aspect of this RSR of published studies, several ongoing planned clinical
trials were identified in the ClinicalTrails.gov website. These clinical studies will evaluate to
use the MDOT approach in TB, stoke, sickle cell disease, HIV patients and in opioid depen-
dence (Table 3).
Furthermore, four conference abstracts were discovered during further manual searches for
relevant studies, all of which discussed TB adherence. Three abstracts were preliminary reports
of main studies while the fourth [50] reported80% adherence in 34 patients. Finally a search
of the internet indicated new developments within the field, e.g. facial recognition in a new
Aicure1 smartphone app in which video review is carried out automatically [51].
Although there is a scarcity of research on the MDOT approach, the work to date suggests
that the approach provides a promising tool to encourage and monitor patient adherence to
prescribed medication. As is customary with the RSR methodology, the main findings of the
review have been summarised in a short statement for ease of reference. This statement is
included in Box 1. As mentioned previously there were no studies which used mobile technol-
ogy in inhaler assessment.
Feasibility study–healthy volunteer children
A total of 12 healthy children and 9 parents participated in this study, i.e. three parents had
two participating children (Table 4). The mean age of children was 7.1 years (age range 2–12
years). Two thirds of the children were female (n = 8). The majority of participating parents
also were female (n = 8). All participants completed recording and submitting videos using the
mobile DOT approach for the entire period of the study (14 days).
A total of 284 video clips were uploaded during the study period. The overall adherence
rate of submitting videos was 84.5% (Fig 2). Two children (aged > 8 years old) completed the
Table 2. Benefits and implementation barriers of using MDOT compared with standard DOT at home or in the
clinic.
1. Benefits of using the MDOT approach
A. For Patients:
▪ Flexible and convenient
▪ Can be used to improve or maintain treatment adherence
▪ Reduce travel burden for patients who live in rural areas with restricted access to medical staff and resources
▪ Can be used as communication tool between patient and medical staff e.g. information on medication side
effects
▪ Can be used for monitoring adherence of immobile and disabled patients
▪ Improves patient privacy and autonomy (e.g. TB patients)
B. For the healthcare system:
▪ Reduced number of medical staff needed for observation
▪ Saves staff time on transport to visit patients at home
▪ Cost effective approach compared with traditional DOT
▪ Can be used to observe patients taking medication at the weekend and public holidays
▪ Improves communication between patients and healthcare provider
2. Impediments to using the MDOT approach
▪ Requires good mobile telephone network coverage (or availability of broadband internet)
▪ Technical problems (e.g. connectivity with mobile network)
▪Data security and confidentiality could be compromised when using public telecommunication networks
(unless videos are encrypted)
▪Difficulty in technology use by some patients (e.g. severe arthritis or poor vision)
DOT = Direct Observation of Therapy
MDOT = Mobile Direct Observation of Therapy
https://doi.org/10.1371/journal.pone.0190031.t002
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study without missing any video uploads (100% upload adherence; Table 4). Only one partici-
pant had an upload adherence rate of less than 75%. The latter was attributed to arrangements
at weekends as the child visited a second parent’s home (father) and this parent was not partic-
ipating in the study. A study which examined adherence to renal medication in children is
consistent with our finding that change of routine at weekends can result in a drop in adher-
ence rate [52]. A range of different mobile devices (using either Apple or Android operating
systems) were used by the participants in the study (Table 4).
The majority (87.1%) of uploaded videos via the MDOT system were judged to be of
acceptable quality, 11.25% marginally acceptable and 1.65% of unacceptable video quality (due
to poor lighting at home or improper framing of the video capture).
A total of eight children and nine parents were interviewed after they completed the video
upload aspect of the study. The vast majority of children were satisfied with the MDOT system.
Parents reported that their children were enthusiastic and interested in the use of the MDOT
approach in this project, particularly older children. Older children themselves mentioned that
twice daily recoding of their use of the inhaler was fun and enjoyable. In the case of only one
Table 3. Ongoing or planned clinical trials using the MDOT approach in assessing treatment administration (information obtained from ClinicalTrial.gov website,
accessed on Feb 2016).
Lead researcher Clinical trial title Study design Participants Intervention Starting
date
Estimated
study
completion
date
Richard Garfeine
Department of
Medicine, UC
San Diego
(USA)
Video directly observed
therapy (VDOT) for
monitoring adherence to
latent tuberculosis treatment
(LTBI)
Randomised parallel
assignment study where
video arm compared
with attending in-person
arm.
Participant age
for recruitment:
13 years and
older.
Application for smartphone that
enables tuberculosis (TB) patients to
record and send videos of each
medication dose ingested. These
videos to be viewed by healthcare
workers.
January
2016
December
2019
Daniel Labovitz,
Montefiore
Medical Center
(USA)
Using artificial intelligence to
measure and optimise
adherence in patients on
anticoagulation therapy.
Randomised
intervention; parallel
assignment.
Compared with
unmonitored group.
Participant age
for recruitment:
18 years and
older.
Mobile App to be downloaded onto a
smart- phone. Artificial intelligence
and visual recognition technology to
be used to verify medication ingestion.
March
2015
March 2016
Susan Creary,
Nationwide
Children’s
Hospital
(USA)
Electronic hydroxyurea
adherence: a strategy to
improve hydroxyurea
adherence in patients with
sickle cell disease.
This is a non-
randomised
intervention. Crossover
study design.
Children and
adults to be
recruited.
MDOT based on patients’
smartphones. Electronic reminder
alerts sent to patients. Video recording
of patients’ daily hydroxyurea
administration
July 2014 December
2017
Not provided
(Moldova)
Virtually observed treatment
(VOT) for tuberculosis in
Moldova
Randomised
parallel assignment
compared with control
care group.
Participants: age
>18 years old
TB patient treatment to be observed
via video submitted via internet
instead of in-person attendance.
Comparison with normal practice of
observing patient at clinic.
October
2015
February 2017
Anthony
DeFulio,
National
Institute on Drug
Abuse (NIDA)
(USA)
SteadyRx: smartphone ART
adherence intervention for
drug users
Randomised
parallel assignment
compared with usual
care group
Participants aged
18 to 65 years old.
Mobile App will automatically
facilitate consultation of human
immunodeficiency virus (HIV)
patients with care providers, provide
reminders when a dose is overdue, and
provide electronic remote observation
of medication taking.
Not
specified
February 2017
Alain Litwin,
Montefiore
Medical Center
(USA)
Using artificial intelligence to
monitor medication
adherence in opioid
replacement therapy
Single group assignment Participants aged
>18 years old
This study will use an artificial
intelligence platform via mobile app to
automatically confirm medication
ingestion of opioid dependence. In
case of missed dose, an alert message
will be sent via text message or Email.
March
2016
March 2017
https://doi.org/10.1371/journal.pone.0190031.t003
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child, the parent stated that he got somewhat bored by the end of the two week study. The
present findings are consistent with a study carried out in children with sickle cell disease in
which children accepted and were satisfied with daily recoding of their medication use, in this
latter case over a prolonged period of six months [13]. Participants in the pilot study provided
a variety of different suggestions to improve the use of the MDOT methodology, despite most
children and parents finding the use of the MDOT system to be very easy and straightforward.
The main improvement suggested was to have a more colourful interface and the provision of
feedback to the parent/child that the video had been uploaded successfully. Multiple studies
have shown that the use of mobile phone apps are acceptable to patients in assisting in the
management of HIV, TB and diabetes management [45,53,54] and this was certainly the case
in the present study. The training time for each participant on how to capture videos and
upload them using the MDOT platform was short, i.e. the session for software installation,
Box 1. RSR report—MDOT in treatment adherence
Research question
- What is the current evidence in the published literature concerning the effectiveness of
the mobile direct observation therapy (MDOT) approach in treatment adherence?
The main purpose of this rapid review
The purpose of the review was to gather evidence about the feasibility and effectiveness
of the MDOT approach in monitoring medicine adherence.
The key messages of this rapid review
▪ The MDOT approach is feasible and promising for observing treatment remotely
▪ Although several studies have demonstrated the feasibility of recording videos of
treatment administration via a mobile device and sharing this with healthcare pro-
viders (or real time viewing of treatment administration using a videophone), no
robust, randomised studies have been published to date. Several ongoing studies
were reported in the ClinicalTrail.gov website in which randomised recruitment is
ongoing to larger studies.
▪ The MDOT approach can provide multiple benefits for patients and the healthcare
system. The flexible and convenient approach, reduces the burden for patients and
saves public resources.
▪ The approach has been used to date mainly in the treatment of TB and Sickle cell
disease.
▪ There was a lack of methodological rigor and overall quality in the studies pub-
lished to date in assessing the effectiveness of MDOT in treatment adherence.
▪ Evidence of the effectiveness of MDOT in assessing and promoting treatment
adherence is currently insufficient and, therefore, further research should be con-
ducted in this evolving area.
Mobile direct observation therapy of inhaler use
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MDOT demonstration and training took approximately 30 minutes. With regard to the time
required to use the MDOT approach, approximately five minutes was required for the com-
plete MDOT process, including preparation time. These times are consistent with other
MDOT studies that reported time requirements of less than 5 minutes [13,42,49].
In general, there were no major technical problems with the current MDOT system during
the study. One parent living in a rural location reported some difficulty with a slow internet
connection. Another parent had some difficulty with the size of the video clips, however, this
was easily overcome by downgrading of the resolution in the mobile phone camera. It was
observed, based on the videos submitted, that poor lighting in the room used to prepare videos
Table 4. Demographics of participating children, MDOT adherence rate and the mobile devices used in the feasibility study.
Patient
ID
Parent
ID
Child
gender
Parent
gender
Age of child
(years)
No. of uploaded
videos
No. of days missed at least
1 video
Mobile DOT
adherence %
Device brand used for
MDOT
C1 P1 F F 11 26 1 92.8 ipad (Apple)
C2 P1 F F 5 25 2 89.2 ipad (Apple)
C3 P3 M F 7 11 9 39.2 Iphone(Apple)
C4 P4 F F 5 24 2 85.7 HTC phone (Android)
C5 P5 F F 6 24 2 85.7 iphone(Apple)
C6 P5 F F 2 24 2 85.7 Ipad (Apple)
C7 P7 F F 6 22 3 78.5 Iphone (Apple)
C8 P8 M F 3 22 3 78.5 Iphone (Apple)
C9 P9 M M 10 28 0 100 Hudl tablet (Android)
C10 P10 F F 8 27 1 96.4 Huawei Tablet
(Android)
C11 P10 F F 10 28 0 100 Huawei Tablet
(Android)
C12 P12 M F 12 23 3 89.28 iphone (Apple)
MDOT = Mobile Direct Observation of Therapy
https://doi.org/10.1371/journal.pone.0190031.t004
Fig 2. Mobile DOT video upload adherence in the feasibility study.
https://doi.org/10.1371/journal.pone.0190031.g002
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or the participant being too far away from the mobile phone affected video clarity. This point
was also highlighted by Hoffman et al. [45]. It was noted that the mobile device stand provided
to each participant helped participants in the self-capture of the video clips without any assis-
tance from others. In addition, it enabled participants to control the framing themselves and
facilitated video stability. One parent reported the benefit of the mobile stand, as follows: “Not
at all complicated. We had to adjust the little device for propping up the iPad with. She knew
when the angle is correct. She is pretty good checking it. She will be keeping an eye to see that
it was at the right angle” (parent of child aged 11 years). The results of this feasibility study con-
firm that this monitoring system for inhaler use is feasible and could be suitable to monitor
child inhaler use within a clinical setting. Furthermore, it has the potential to monitor the cor-
rect steps of inhaler use and in monitoring adherence in children.
Pilot study in children with asthma
A total of 34 eligible patients were approached across the two study sites. Twenty two children
and their parents completed the study (Fig 3). Reasons for non-participation and withdrawals
from the study are reported within Fig 3. For the purpose of this pilot study analysis, due to the
small numbers of patients involved, data sets from the IM and DE groups were combined and
data were compared between baseline and 12 weeks post the initiation of DOT.
Patient demographics. The gender distribution of children was 17 male and 5 female.
The age range of children entering the study was 2–16 (mean 9.4 + 3.7 years). The mean (+ SD)
ACT scores in the participating patients were 13.1+ 5.7 at baseline while the mean (+ SD) FeNO
levels at baseline were 38.7 + 28.8 PPM. Over 50% of the cohort (12/22) had been prescribed
oral steroids in the year prior to study entry and approximately 40% (9/22) had used ‘out of
hours’ GP services in the previous year. The majority (13/22) had a comorbid illness, primarily
hay fever and eczema.
Inhaler technique. Despite all children being able to demonstrate good inhaler technique
during study enrolment at the clinic, a total of 77% (17/22) of the participants had partially
effective or poor inhaler technique in the first week of MDOT assessment. This is an important
finding indicating that satisfactory technique at the clinic is not carried forward to home use. By
week 4 of MDOT engagement, approximately 90% (17/19) of the children had inhaler tech-
nique which was judged as effective (Table 5). At this stage, 3 patients had stopped recording
their inhaler use and were not responding to phone calls or text messages. By week 5 all children
still enrolled in the study (n = 18) were judged to have effective inhaler technique, i.e. inhaler
technique improved after tailored inhalation instructions over the telephone by a member of
clinical team. From inhaler observation, slow inspiration was found to be the most common
mistake related to the use of dry power inhalers while forgetting to shake the inhaler before use
and poor sealing of lips around the mouthpiece were common with pressured aerosol inhalers.
Influence of MDOT on outcomes. A summary of the data on impact of the MDOT inter-
vention on asthma outcomes, 12 weeks post the initiation of the intervention is presented in
Table 6. The two main markers of asthma control (ACT and FeNO) were improved signifi-
cantly (P<0.05) at the 12 week assessment; the minimum clinical difference required (i.e. 3
points in the ACT) to mark improved asthma control was achieved [55]. The MDOT approach
also led to a reduction in the mean FeNO value (PPM) to normal levels, i.e. 38.7+28.8 (n = 22)
to 19.3 + 14.4 (n = 16) (Table 6). Within this small pilot sample spirometry values did not vary
to a statistically significant degree between baseline and 12 weeks (P>0.05).
All parents/guardians (n = 22) completed the QOL questionnaires (PACQLQ) at baseline
while 19 parents completed the questionnaire at 12 weeks post initiation of DOT. The results
demonstrated improved QOL at 12 weeks compared with baseline (P< 0.001). A mean score
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of> 4 (moderate to excellent QOL) was achieved by participants at week 12. A total of 12 chil-
dren > 9 years old completed the QOL questionnaire (PAQLQ) at baseline and at 12 weeks
post initiation of MDOT. An improvement in the mean score of greater than one unit was
achieved, however, this did not reach statistical significance (p = 0.079; Table 6). A statistically
significant correlation were found between ACT scores and parent QOL scores at baseline
(r = 0.55; p<0.001) and at 12 weeks post MDOT initiation (r = 0.74; p<0.001). Similarly, statis-
tically significant correlations were found between ACT scores and child QOL scores at base-
line (r = 0.75; p<0.001), and at 12 weeks post MDOT initiation (r = 0.65; p<0.001). Clinician
assessment of asthma control indicated that at 12 weeks post initiation of the intervention,
patients were moving towards the partially controlled or controlled categories, with a marked
reduction in the patients deemed uncontrolled i.e. 14 at baseline vs 4 at 12 weeks (Table 6).
Fig 3. Number of children who participated in the pilot study in children with asthma.
https://doi.org/10.1371/journal.pone.0190031.g003
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Adherence to video upload. A total of 1083 video clips were recorded and uploaded during
the six week MDOT period by participants. Using the video upload approach, 72.7% of the chil-
dren (16/22) achieved moderate adherence to video uploads ( 50%) for the intervention
period. The frequency / reasons for not uploading videos were as follows: busy schedule (e.g.
school exam)– 6; child visits father’s home at weekend and father not trained in MDOT process–
3; forget to take video– 3; large video file size -3 (corrected by decreasing video resolution on
mobile phone); lost phone– 2; no space on mobile phone storage– 2; child was unwell (e.g. gas-
troenteritis)– 2; mother was admitted to hospital– 2; travelling outside the country– 1. A total of
four participants had a video upload adherence rate of less than 30%. There is clear scope for sig-
nificant improvement in this aspect of MDOT including automated reminders, video compres-
sion (to reduce memory requirements on the mobile device), familiarisation of more than one
family member with MDOT and perhaps a reduced frequency of monitoring (e.g. one upload
each evening, with a tick box to confirm whether the inhaler has been used in the morning).
Adherence to inhaler use (GP records and MARS). All of the GP prescribing data
requested were received. Using the cut point of 80%, 10 children (45.4%) were deemed adher-
ent and 12 children (54.6%) were classified as non-adherent in the 12 months prior to enrol-
ment in the present study.
All 22 parents/guardians of the children who participated in the study completed the
MARS questionnaires at baseline. Using a cut point of 80% of the maximum score achiev-
able to represent adherence, the level of non-adherence reported for the participants was 18.2%
Table 5. Classification of inhaler technique in children during the 6 week use of the MDOT approach in the pilot study in children with asthma.
Child ID 1st week 2nd week 3rd week 4th week 5th week 6th week
DE1 P. effective Effective Effective P. effective Effective Effective
DE2 Poor P. effective Effective Effective Effective Effective
DE3 P. effective P. effective Effective Effective ———————— —————————
DE4 Effective Effective Effective Effective Effective Effective
DE5 P. effective Effective P. effective Effective Effective Effective
DE6 Poor P. effective P. effective Effective Effective Effective
DE7 Effective Effective Effective Effective Effective Effective
DE8 Poor Effective Effective Effective Effective Effective
DE9 Effective Effective Effective Effective Effective Effective
DE10 P. effective P. effective —————————— —————————— ———————— —————————
IM1 P. effective Effective P. effective Effective Effective Effective
IM2 P. effective Effective Effective Effective Effective Effective
IM3 P. effective P. effective Effective Effective Effective Effective
IM4 P. effective P. effective Effective P. effective Effective Effective
IM5 Effective P. effective Effective Effective Effective Effective
IM6 Poor —————————— ————————— ————————— ———————— ————————
IM7 P. effective P. effective P. effective Effective Effective Effective
Im8 P. effective P. effective Effective Effective Effective Effective
IM9 P. effective P. effective Effective Effective Effective Effective
IM10 P. effective Effective Effective Effective Effective Effective
IM11 P. effective Effective P. effective Effective Effective Effective
IM12 Effective Effective Effective ——————————— ———————— —————————
 Stopped recording and did not respond to phone or text messages
P. effective = partially effective technique
MDOT = Mobile Direct Observation of Therapy
https://doi.org/10.1371/journal.pone.0190031.t005
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at baseline. Nineteen parents completed the questionnaire at 12 weeks with 0% non-adherence
reported. Regarding the child MARS, 12 children ( 9 years) completed the questionnaire at
baseline with a reported non-adherence rate of 61.5%. By 12 weeks post MDOT initiation,
again 100% adherence was reported by those children. Although the numbers within the pilot
are small, the strong trend towards improvement in self-reported adherence is clear.
Parent feedback on use of MDOT. Feedback from parents was very positive. They found
the MDOT approach: ‘Very easy to access with patient ID, take a video and simply upload’.
There was general support for loading videos twice per day e.g. ‘I think loading videos twice
daily was worthwhile as it drew emphasis to the need to take medication’. Another parent
commented ‘It seems normal to do it twice because it only lasts for a few minutes and does not
take up any time’. Parents were asked whether 6 weeks was an appropriate duration for use of
the MDOT intervention. The responses here were generally supportive of a 6 week interven-
tion, however, some parents thought the intervention could be longer or indeed shorter. A
period of 4–6 weeks seems ideal. Variable answers were provided to the question regarding
what age a child could use the MDOT independently. The most pertinent answer was that: ‘If a
child is able to use a smartphone, they would not find any problems’ and indeed one parent
reported: ‘My child of 5 years old was able to use it’. Other parents suggested ages of 8–13
years old as being appropriate for self-use of MDOT.
The main barrier reported by parents was slow uploading of videos when internet / mobile
network speeds were slow and on a few occasions videos did not upload. Parents were asked to
suggest improvements to the MDOT platform. One suggested: ‘Maybe a little alarm would be
useful’ while another suggested that there ‘could be a place to upload comments along with the
video of inhaler use to help the doctor know how the child is getting on’. Both those sugges-
tions are being incorporated into a redeveloped MDOT platform (www.continga.co.uk).
Advantages of using the MDOT proffered by parents were focused on (i) observing inhaler
technique, (ii) monitoring / improving treatment and (iii) working as a reminder. Typical
comments within these three areas respectively were: (i) ‘I think it is a great idea because the
doctor is able to see how the child is using the inhaler’; ‘It has been a great help in finding out
faults’, (ii) ‘I think it is great as [it] showed children are getting [the] correct treatment’; ‘I
Table 6. Summary data on impact of MDOT intervention on asthma outcomes (at 12 weeks post initiation of MDOT) in the pilot study in children with asthma.
Outcomes Baseline
Mean ± SD
12 weeks post MDOT
Mean ± SD
p–value
Asthma control
ACT
13.1±5.7 17.8±4.3 0.007
FeNO (PPM) 38.7±28.8 19.3±14.4 0.019
Spirometric value
FEV1%
91.9±13.1 92.8 ± 10.5 0.721
FEV1/FVC% 92.6± 10.9 92.8±10.5 0.952
Child QOL
(PAQLQ) (9 years)
3.8±1.6 4.9±1.5 0.079
Parent QOL
(PACQLQ)
3.7±1.4 5.4±1.3 0.001
Clinical assessment of asthma
Controlled
0 7 -
Partly controlled 8 11 -
Uncontrolled 14 4 -

Independent T test (Significant at p<0.05)
MDOT = Mobile Direct Observation of Therapy
https://doi.org/10.1371/journal.pone.0190031.t006
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think 6 weeks was ideal because it got my son into a routine and he still is on it’; ‘It is good to
learn how to control your child’s asthma’; ‘It gives parent peace of mind to know that the child
with asthma is controlled right’, (iii) ‘It helped my son remember to take his inhalers twice
daily’. Our findings support the views of other users (with other chronic illness) that the
MDOT approach is convenient, not time consuming and with minimal disruption can be inte-
grated into routine daily activities (Table 1).
As detailed earlier a small number of parents agreed to use the MDOT but either did not
get started with the MDOT monitoring or discontinued early. Reasons for this were generally
related to practical matters e.g. parking difficulties at hospital (parent did not have mobile
phone at clinic visit and did not return to get the MDOT software uploaded; not being at
home when child was using inhaler due to shift work; difficulty getting up in the mornings to
help child. Approaches to overcome some of these logistical challenges are currently being
developed by the research team.
The overall assessment of the pilot study by the researchers is that all aspects of study ran
very much as planned. Although this is a small pilot study, the clinical outcome improvements
at 12 weeks post MDOT initiation were encouraging as was the acceptability of the MDOT
approach to parents and children. The focus of the pilot study was on improvements from
baseline when the MDOT intervention was in place. It was noted, however, that there were
improvements in the DE group outcome measures (particularly FeNO) at the end of the 6
week period at the start of the study i.e. before the MDOT intervention was initiated in that
group. This was likely due to their enrolment in a clinical trial and becoming better engaged in
their therapy because of this (Hawthorne effect). These aspects will be explored further in a
larger study that is being planned by members of the research team. The MDOT approach has
been used successfully for prolonged periods in TB management. However, since medication
adherence is known to drop off over time in children [56] future research is required to ascer-
tain if adherence to MDOT deteriorates over longer term use in inhaler management. Further
work is also required to ascertain exactly how long MDOT is needed for to give rise to sus-
tained improvement in inhaler technique and if further specific interventions are required to
give rise to sustained adherence to the MDOT intervention.
Conclusions
MDOT is a technology that has the potential to be a cost effective approach (patient does not
have to attend clinic or observer does not have to visit patient) to direct observation of therapy
administration, the latter being one of the most accurate methods of evaluating adherence. It
could also be potentially useful for children whose caregivers have busy schedules and find it
difficult to attend scheduled clinics. Use to date, as confirmed by the rapid systematic review,
has been limited mainly to TB and sickle cell disease and there have been no published reports
on the use of MDOT to monitor inhaled therapy. Due to the increasing incidence of childhood
asthma worldwide, there is a need for new innovative approaches to support children and
their parents with asthma management, especially since national and international guidelines
have advised healthcare providers to periodically assess inhaler use as part of asthma manage-
ment [57,58].
After successful testing of the feasibility of using MDOT to assess inhaler technique and
adherence in healthy volunteer children, the present programme of work went on to assess, in
a pilot study, the impact of the approach in children with poorly controlled asthma. The results
from the pilot study were also very encouraging, with children who received the MDOT inter-
vention showing significant improvement in the two main markers of successful asthma man-
agement, i.e. the ACT and FeNO. It is perhaps worthwhile restating that all patients enrolled
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were receiving care from a specialist asthma clinic and had received best practice education
ahead of joining the study.
Checking the uploaded videos allowed patients to be contacted if their inhaler technique
was deteriorating (which it often did during the early phase of the intervention) or if videos
had not been uploaded. This approach is obviously much more cost efficient when compared
with DOT. Although it can be used to monitor inhaler adherence, a potential issue is that a
patient may use the inhaler but forget or not bother to make and upload the video of the
administration. This aspect of the overall intervention requires some further thought, perhaps
an inbuilt reward system to encourage full engagement would be helpful. Also it could be the
case that once per day uploading of inhaler use would be sufficient to engage patients / parents
and check on inhaler use, with a simple tick box to be completed to record the second daily
use of the inhaler. It was noted in the feasibility and pilot studies that the MDOT approach and
the IT platform employed was easy to use and with the exception of a few instances where
internet connectivity was poor, good quality videos (including the sound of inhaler activation
and patient inspiration) could be easily captured and transmitted. It was also noted that the
approach allowed the development of a bilateral partnership and communication between the
treatment team and the parent / guardian of the child or indeed older children themselves.
This is the first research study which has examined adherence technique and inhaler use in
children using the MDOT approach. The approach could be particularly useful in ensuring
asthma patients are adherent to low cost standard therapies ahead of being prescribed expen-
sive biological treatments. It also has the economic advantage that adherence can be monitored
A major advantage of the approach is that individual steps in inhaler use can be easily followed,
regardless of inhaler type. The very positive results should promote further adoption of, and
research on, this approach in children with asthma and in other conditions across the wider
population in an attempt to overcome the scourge of non-adherence which has plagued phar-
macotherapy over many years.
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